Skip to main content

Table 3 Odds ratios of breast cancer risk in relation to p-mTOR expression associated with body size measurements by tumor ER status

From: Body fatness and breast cancer risk in relation to phosphorylated mTOR expression in a sample of predominately Black women

Body size measurement

 

ER+ tumors

  

ER– tumors

 

p-mTOR overexpressed cases vs controls

p-mTOR negative/low cases vs controls

P-heterogeneity

p-mTOR overexpressed cases vs controls

p-mTOR negative/low cases vs controls

P-heterogeneity

OR (95% CI)

OR (95% CI)

 

OR (95% CI)

OR (95% CI)

 

BMI, kg/m2

 No. of cases/no. of controls

164/1973

309/1973

 

25/1973

211/1973

 

  < 25

1.00 [reference]

1.00 [reference]

 

1.00 [reference]

1.00 [reference]

 

 25–29.99

1.29 (0.77–2.16)

1.02 (0.72–1.45)

 

0.83 (0.23–2.99)

1.00 (0.68–1.49)

 

 30–34.99

1.48 (0.87–2.52)

1.33 (0.92–1.91)

 

1.72 (0.54–5.48)

0.84 (0.54–1.31)

 

  ≥ 35

1.39 (0.82–2.34)

0.75 (0.51–1.11)

0.015

0.90 (0.25–3.25)

0.61 (0.39–0.96)

0.09

P-trend

0.27

0.18

 

0.97

0.015

 

WC

 No. of cases/no. of controls

162/1955

304/1955

 

25/1955

206/1955

 

 Q1

1.00 [reference]

1.00 [reference]

 

1.00 [reference]

1.00 [reference]

 

 Q2

1.65 (0.90–3.01)

1.09 (0.74–1.60)

 

1.81 (0.32–10.1)

1.09 (0.70–1.70)

 

 Q3

2.28 (1.28–4.06)

1.36 (0.93–1.98)

 

4.70 (1.00–22.07)

1.04 (0.57–1.63)

 

 Q4

1.93 (1.06–3.51)

1.01 (0.67–1.50)

0.26

2.60 (0.50–13.6)

0.83 (0.52–1.32)

0.55

P-trend

0.050

0.97

 

0.25

0.31

 

WHR

 No. of cases/no. of controls

162/1955

304/1955

 

25/1955

206/1955

 

 Q1

1.00 [reference]

1.00 [reference]

 

1.00 [reference]

1.00 [reference]

 

 Q2

1.17 (0.57–2.04)

1.34 (0.91–1.98)

 

1.58 (0.26–9.59)

1.34 (0.85–2.10)

 

 Q3

1.54 (0.91–2.60)

1.47 (1.00–2.15)

 

5.35 (1.16–24.71)

1.28 (0.80–2.03)

 

 Q4

1.69 (1.01–2.84)

1.37 (0.93–2.03)

0.36

3.42 (0.68–17.16)

1.60 (0.99–2.58)

0.89

P-trend

0.027

0.14

 

0.08

0.38

 
  1. Abbreviations: BMI body mass index, ER estrogen receptor, OR odds ratio, Q quartile, WC waist circumference, WHR waist-to-hip ratio
  2. Models adjusted for age, race, family history of breast cancer, menopausal status, age of menarche, parity, history of breastfeeding, oral contraceptive use, and history of diabetes